a phase ii study of mitoxantrone ( mit ) was performed in 13 cases of refractory malignant lymphoma , 1 of hodgkin 's disease and 12 of non-hodgkin lymphoma .
C0024299
malignant lymphoma
C0024305
non-hodgkin lymphoma